Does TERAZOSIN Cause Basal cell carcinoma? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Basal cell carcinoma have been filed in association with TERAZOSIN (terazosin). This represents 0.9% of all adverse event reports for TERAZOSIN.
5
Reports of Basal cell carcinoma with TERAZOSIN
0.9%
of all TERAZOSIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Basal cell carcinoma From TERAZOSIN?
Of the 5 reports.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Therapeutic product effect incomplete (75)
Asthma (66)
Dyspnoea (60)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which TERAZOSIN Alternatives Have Lower Basal cell carcinoma Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE